Isolated hemopericardium after initiation of rivaroxaban: Implications and potential mechanisms
Direct oral anticoagulants have become increasingly used for atrial fibrillation and venothromboembolic disease. Thus far, there have been a few published cases of pericardial effusion associated with rivaroxban. However, there has been little published regarding the effects of concurrent medication...
Main Authors: | Adwait Mehta, David Burkland, Nilesh Mathuria |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-01-01
|
Series: | Clinics and Practice |
Subjects: | |
Online Access: | https://www.clinicsandpractice.org/index.php/cp/article/view/1096 |
Similar Items
-
NAT2 phenotype alters pharmacokinetics of rivaroxaban in healthy volunteers
by: Gonzalo Villapalos-García, et al.
Published: (2023-09-01) -
Rivaroxaban in acute venous thromboembolism: UK prescribing experience
by: Victoria Speed, et al.
Published: (2021-10-01) -
First reported case series in the United States of hemopericardium in patients on apixaban
by: Naveen Sablani, MD, MS, et al.
Published: (2018-02-01) -
Dosing-time-dependent effect of rivaroxaban on coagulation activity in rats
by: Yuki Fujiwara, et al.
Published: (2017-08-01) -
Rivaroxaban in non valvular atrial fibrillation: subgroups analysis
by: Cesare Greco
Published: (2015-08-01)